Cargando…
Do clinical trials truly mirror their target population? An external validity analysis of national register versus trial data from the Swedish prospective SENOMIC trial on sentinel node micrometastases in breast cancer
PURPOSE: Increasing evidence suggests that completion axillary lymph node dissection (ALND) may be omitted in breast cancer patients with limited axillary nodal metastases. However, the representativeness of trial participants for the original clinical practice population, and thus, the generalizabi...
Autores principales: | Andersson, Y., Bergkvist, L., Frisell, J., de Boniface, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661061/ https://www.ncbi.nlm.nih.gov/pubmed/31236811 http://dx.doi.org/10.1007/s10549-019-05328-3 |
Ejemplares similares
-
The generalisability of randomised clinical trials: an interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer
por: de Boniface, Jana, et al.
Publicado: (2020) -
Swedish prospective multicenter trial on the accuracy and clinical relevance of sentinel lymph node biopsy before neoadjuvant systemic therapy in breast cancer
por: Zetterlund, Linda, et al.
Publicado: (2017) -
Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer
por: Zetterlund, Linda Holmstrand, et al.
Publicado: (2017) -
External Validation of the SERC Trial Population: Comparison with the Multicenter French Cohort, the Swedish and SENOMIC Trial Populations for Breast Cancer Patients with Sentinel Node Micro-Metastasis
por: Houvenaeghel, Gilles, et al.
Publicado: (2020) -
Prediction of Non-Sentinel Lymph Node Status in Breast Cancer Patients with Sentinel Lymph Node Metastases: Evaluation of the Tenon Score
por: Andersson, Y, et al.
Publicado: (2012)